Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
24 hedge funds and large institutions have $8.2M invested in Marrone Bio Innovations, Inc. in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
4% more funds holding
Funds holding: 23 → 24 (+1)
9% less capital invested
Capital invested by funds: $8.98M → $8.2M (-$782K)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$409K |
| 2 |
Goldman Sachs
New York
|
+$8.78K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$7.87K |
| 4 |
EAM
Evanson Asset Management
Carmel,
California
|
+$3.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$227K |
| 2 |
Primecap Management
Pasadena,
California
|
-$122K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$33.4K |
| 4 |
Millennium Management
New York
|
-$28.6K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$4K |
MBII Hedge Fund Activity: Q2 2016 in Review
24 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2016, worth a combined $8.2M — down 8.7% from $8.98M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MBII positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Ardsley Advisory Partners, opening a new position worth an estimated $409K. The largest seller was Senvest Management, cutting an estimated $227K.
- 24 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2016, up from 23 in Q1 2016.
- Funds reported $8.2M of Marrone Bio Innovations, Inc. stock for Q2 2016, down 8.7% quarter-over-quarter.
- 5 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2016 and 3 closed out, a net change of +2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2016 was Ardsley Advisory Partners, an estimated $409K added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2016 was Senvest Management, an estimated $227K sold.
Based on aggregated 13F filings for Q2 2016.